Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 209
interventional 173
Observational 32
Registry 4

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 77
Drug|placebo 46
Dietary Supplement 8
Other 7
Behavioral 5
Dietary Supplement|Drug 5
Dietary Supplement|Drug|placebo 4
Device 3
Diagnostic Test 3
Combination Product 2
Dietary Supplement|placebo 2
Drug|Procedure 2
Biological 1
Biological|Drug|placebo 1
Biological|placebo|Procedure 1
Device|Drug 1
Device|Other 1
Dietary Supplement|Drug|Other 1
Dietary Supplement|Other 1
Other|Procedure 1
Other|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 42
NA 34
China 8
Korea, Republic of 4
Turkey 4
United Kingdom 4
United States|Canada 4
Germany 3
Italy 3
United States|Puerto Rico 3
Canada 2
Denmark 2
Greece 2
Japan 2
Spain 2
United States|Argentina|Brazil|Czech Republic|Denmark|Estonia|Hong Kong|Lithuania|Poland|Romania 2
Armenia 1
Australia|Italy|Poland|Spain|Sweden 1
Austria 1
Austria|Belgium|Greece|Ireland|Luxembourg 1
Belgium|Germany|Sweden 1
Bosnia and Herzegovina 1
Brazil 1
Canada|United States|Argentina|Brazil|Bulgaria|Israel|Mexico|Romania|Russian Federation 1
Czech Republic|Germany|Greece|Israel|Mexico|Spain 1
Denmark|Estonia 1
Denmark|Germany 1
Finland 1
Finland|Netherlands|Norway|Spain|Sweden 1
France 1
Hong Kong|Indonesia|Philippines|Taiwan|Thailand 1
India 1
Ireland 1
Israel 1
Norway 1
Poland|Hungary|Latvia|Romania|Russian Federation|Slovakia|Slovenia 1
Puerto Rico 1
Russian Federation 1
Serbia 1
Sweden 1
Switzerland 1
Taiwan 1
Turkey|Albania|Bosnia and Herzegovina|Croatia|Macedonia, The Former Yugoslav Republic of|Serbia 1
United Kingdom|United States|Poland 1
United States|Argentina|Australia|Austria|Belgium|Canada|Czech Republic|Denmark|Finland|France|Germany|Hungary|Israel|Italy|Mexico|Netherlands|New Zealand|Norway|Poland|Singapore|Slovakia|Slovenia|Spain|Sweden|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Canada|Czech Republic|Denmark|Finland|Hungary|Israel|Italy|Netherlands|New Zealand|Norway|Poland|Sweden 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Colombia|Czechia|Denmark|Dominican Republic|Estonia|Germany|Hungary|India|Japan|Latvia|Lithuania|Mexico|New Zealand|Poland|Romania|Spain|Switzerland|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Estonia|Finland|France|Hungary|Lebanon|Norway|Poland|Spain 1
United States|Argentina|Australia|Belgium|Brazil|Canada|France|Germany|Italy|Mexico|Puerto Rico|Spain|Sweden 1
United States|Argentina|Australia|Belgium|Canada|Colombia|Finland|France|Germany|Hong Kong|Hungary|Italy|New Zealand|Norway|Poland|Sweden|Switzerland|Thailand 1
United States|Argentina|Australia|Canada|Czech Republic|France|Lebanon|Poland|South Africa|Turkey|United Kingdom 1
United States|Argentina|Australia|Canada|France|Italy|Spain|Taiwan 1
United States|Argentina|Austria|Belgium|Brazil|Canada|Czechia|France|Germany|Greece|Hungary|Italy|Poland|Puerto Rico|Spain 1
United States|Argentina|Belgium|Canada|Colombia|Czechia|Denmark|Hungary|Poland|Spain|United Kingdom 1
United States|Argentina|Belgium|Canada|Estonia|France|Hungary|Poland 1
United States|Argentina|Brazil|Mexico|South Africa|Switzerland 1
United States|Australia|Belgium|Brazil|Canada|Czechia|Denmark|France|Germany|Hungary|Italy|Mexico|Norway|Poland|Romania|South Africa|Spain|Switzerland|United Kingdom 1
United States|Australia|Belgium|Canada|Czech Republic|Denmark|France|Germany|Hungary|Italy|Mexico|Norway|Poland|South Africa|Spain|United Kingdom 1
United States|Australia|Belgium|Canada|Denmark|Poland|Spain 1
United States|Australia|Belgium|Canada|France|Netherlands|United Kingdom 1
United States|Australia|Belgium|Czech Republic|Denmark|France|Germany|Hungary|Italy|Mexico|Norway|Poland|South Africa|Spain|United Kingdom 1
United States|Belgium|Brazil|Czechia|Denmark|France|Germany|Hungary|Italy|Mexico|Norway|Poland|Spain|United Kingdom 1
United States|Bulgaria|Hungary|Poland|South Africa|United Kingdom 1
United States|Canada|Denmark|Poland 1
United States|Czechia|Poland 1
United States|Denmark|Estonia|Poland 1
United States|Germany|United Kingdom 1
United States|Mexico|Netherlands|Spain 1

Sites per Study

Site_count Study_Count
1 94
2 7
3 3
4 5
5 7
6 3
7 4
8 1
9 2
10 5
11 3
12 2
13 1
15 1
17 2
19 1
20 1
21 1
23 1
25 1
27 2
28 1
31 1
32 1
39 1
44 1
45 2
46 1
48 1
49 1
50 1
52 1
53 1
54 1
57 2
60 1
64 1
68 1
72 1
78 1
103 1
142 1
174 1
191 1
218 1

Phase

Phase Study_Count
Phase 3 53
Phase 4 52
N/A 29
Phase 2 22
Phase 1 15
Phase 1/Phase 2 1
Phase 2/Phase 3 1

Number of Arms

Number_of_Arms Count_of_Studies
1 22
2 80
3 24
4 10
5 2
6 1
7 1
8 1
NA 32

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 10.0000 15.000 148 15.00 105 23.000 22.0000
1st Qu. 33.0000 30.000 148 92.75 105 199.750 72.2500
Median 52.0000 56.000 148 222.00 105 440.000 233.5000
Mean 100.6897 2373.923 148 217.55 105 1163.923 362.3462
3rd Qu. 91.0000 104.000 148 291.25 105 1064.500 484.2500
Max. 1100.0000 30000.000 148 526.00 105 9369.000 2433.0000

Trial Group Type

group_type Group_Count
Experimental 158
Active Comparator 102
Placebo Comparator 50
NA 32
Other 11
No Intervention 4

Intervention Model

intervention_model Study_Count
Parallel Assignment 124
Single Group Assignment 26
Crossover Assignment 14
Factorial Assignment 4
NA 4
Sequential Assignment 1

Primary Purpose

primary_purpose Study_Count
Treatment 134
Prevention 16
Basic Science 5
NA 5
Diagnostic 4
Supportive Care 4
Other 3
Screening 2

Observational Studies

Studies by Country

Country Study_Count
Japan 3
Korea, Republic of 3
NA 3
United States 3
Canada 2
France 2
Germany 2
Greece 2
Italy 2
Switzerland 2
Argentina 1
Austria|Belgium|Germany|Greece 1
China 1
Czechia|Slovakia 1
Pakistan 1
Turkey 1
United Kingdom 1
United States|Canada 1

Sites per Study

Site_count Study_Count
1 26
3 2
8 2
29 1
144 1

Enrollment Metrics

Measure Observational
Min 9.000
1st Qu 108.750
Median 298.000
Mean 1136.688
3rd Qu 781.250
Max 10497.000

Observation Model

observational_model Study_Count
Cohort 19
Case-Only 5
Case-Control 3
Other 3
Case Control 2

Time Perspective

time_perspective Study_Count
Prospective 24
Cross-Sectional 7
Retrospective 1

Registries

Studies by Country

Country Study_Count
Belgium 1
China 1
Greece 1
United States 1

Sites per Study

Site_count Study_Count
1 4

Enrollment Metrics

Measure Registries
Min 60.00
1st Qu 90.00
Median 300.00
Mean 377.75
3rd Qu 587.75
Max 851.00

Registry Model

observational_model Study_Count
Cohort 2
Case-Control 1
Ecologic or Community 1

Time Perspective

time_perspective Study_Count
Prospective 4

Follow-up

target_duration Study_Count
1 Year 1
12 Months 1
2 Years 1
6 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03382366 Sarcopenia and Risk of Fall in Osteoporotic Postmenopausal Women https://ClinicalTrials.gov/show/NCT03382366 Recruiting Istituto Ortopedico Galeazzi 2019-05-31
NCT04366726 Study to Evaluate the PK, PD and Usability of Abaloparatide-sMTS in Postmenopausal Women With Low Bone Mineral Density https://ClinicalTrials.gov/show/NCT04366726 Completed Radius Health, Inc. 2019-05-14
NCT03367585 Effects of Vitamin D Supplementation in Muscle Strength and Balance Training https://ClinicalTrials.gov/show/NCT03367585 Completed University of Sao Paulo General Hospital 2018-12-01
NCT03091088 Effects of Physical Exercise to Prevent Osteoporosis in Postmenopausal Women https://ClinicalTrials.gov/show/NCT03091088 Completed University of Valencia 2013-07-01
NCT03026660 Moringa Oleifera on Bone Density https://ClinicalTrials.gov/show/NCT03026660 Completed Appalachian State University 2016-02-29
NCT02981732 CLCF1 Gene Associated With Postmenopausal Osteoporosis of Kidney Yin Deficiency Syndrome https://ClinicalTrials.gov/show/NCT02981732 Recruiting Fujian Academy of Traditional Chinese Medicine 2019-03-31
NCT02884401 Peri-implant Bone Changes in Post-menopausal Osteoporotic Women https://ClinicalTrials.gov/show/NCT02884401 Recruiting Queen Mary University of London 2021-06-30
NCT02822378 Dried Plums and Bone Health in Postmenopausal Women https://ClinicalTrials.gov/show/NCT02822378 Recruiting Penn State University 2021-07-31
NCT02791516 A Safety and Efficacy Study to Evaluate Romosozumab (AMG 785) in South Korean Women With Osteoporosis https://ClinicalTrials.gov/show/NCT02791516 Completed Amgen 2018-02-12
NCT02753283 Preventing Osteoporosis Using Denosumab https://ClinicalTrials.gov/show/NCT02753283 Active, not recruiting University of Pittsburgh 2023-09-30
NCT02604836 A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia https://ClinicalTrials.gov/show/NCT02604836 Completed Hoffmann-La Roche 2006-04-30
NCT02598934 A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis https://ClinicalTrials.gov/show/NCT02598934 Completed Hoffmann-La Roche 2006-05-31
NCT02598453 PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia https://ClinicalTrials.gov/show/NCT02598453 Completed Hoffmann-La Roche 2006-09-30
NCT02598440 A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis https://ClinicalTrials.gov/show/NCT02598440 Completed Hoffmann-La Roche 2005-05-31
NCT02589600 Zoledronic Acid for Osteoporotic Fracture Prevention (ZEST II) https://ClinicalTrials.gov/show/NCT02589600 Active, not recruiting University of Pittsburgh 2021-07-31
NCT00089791 A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis https://ClinicalTrials.gov/show/NCT00089791 Completed Amgen 2008-06-17
NCT02499237 Zoledronic Acid to Maintain Bone Mass After Denosumab Discontinuation https://ClinicalTrials.gov/show/NCT02499237 Completed 424 General Military Hospital 2018-11-30
NCT02478879 A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen https://ClinicalTrials.gov/show/NCT02478879 Completed Zosano Pharma Corporation 2015-11-30
NCT02416947 Soluble Corn Fiber Effect on Bone Resorption in Post Menopausal Women https://ClinicalTrials.gov/show/NCT02416947 Completed Purdue University 2015-01-31
NCT02247011 A 5-Year Follow-up Study Investigating Factors Associated With Osteoporotic Fracture in Chinese Postmenopausal Women https://ClinicalTrials.gov/show/NCT02247011 Completed Peking Union Medical College Hospital 2014-09-30
NCT02176382 Denosumab and Teriparatide Study (DATA-HD and DATA-EX) https://ClinicalTrials.gov/show/NCT02176382 Active, not recruiting Massachusetts General Hospital 2020-01-31
NCT02109042 A Study of Blosozumab (LY2541546) in Postmenopausal Female Participants https://ClinicalTrials.gov/show/NCT02109042 Completed Eli Lilly and Company 2014-07-31
NCT02090400 Switching From Oral Bisphosphonates to Bazedoxifene to Evaluate Effects on Bone Mineral Density in Postmenopausal Women https://ClinicalTrials.gov/show/NCT02090400 Completed Instituto Palacios 2015-07-31
NCT01292187 A Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal Osteoporosis https://ClinicalTrials.gov/show/NCT01292187 Completed Tarsa Therapeutics, Inc. 2012-05-31
NCT01290094 A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-Naïve Women With Post-Menopausal Osteoporosis https://ClinicalTrials.gov/show/NCT01290094 Completed Hoffmann-La Roche 2014-07-31
NCT02016716 A Randomized Phase 3 Study to Evaluate Two Formulations of Romosozumab in Postmenopausal Women With Osteoporosis https://ClinicalTrials.gov/show/NCT02016716 Completed Amgen 2014-09-08
NCT02014467 Denosumab China Phase III Study https://ClinicalTrials.gov/show/NCT02014467 Completed GlaxoSmithKline 2015-08-31
NCT01992159 Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis https://ClinicalTrials.gov/show/NCT01992159 Completed Amgen 2014-10-09
NCT01969656 Safety Study of an Oral Vitamin D Analog in Postmenopausal Women https://ClinicalTrials.gov/show/NCT01969656 Completed Deltanoid Pharmaceuticals 2004-06-30
NCT01881204 Hesperidin and Bone Health in Postmenopausal Women https://ClinicalTrials.gov/show/NCT01881204 Completed Purdue University 2012-10-31
NCT01796301 An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women https://ClinicalTrials.gov/show/NCT01796301 Completed Amgen 2015-05-14
NCT01750086 Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption https://ClinicalTrials.gov/show/NCT01750086 Completed Massachusetts General Hospital 2014-04-30
NCT01732770 Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis https://ClinicalTrials.gov/show/NCT01732770 Completed Amgen 2015-01-07
NCT01709110 VERtebral Fracture Treatment Comparisons in Osteoporotic Women https://ClinicalTrials.gov/show/NCT01709110 Completed Eli Lilly and Company 2016-07-31
NCT01674621 Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosis https://ClinicalTrials.gov/show/NCT01674621 Completed Radius Health, Inc. 2013-08-02
NCT01657162 Twenty Four Month Extension Study of BA058-05-003 https://ClinicalTrials.gov/show/NCT01657162 Completed Radius Health, Inc. 2016-10-31
NCT01653275 Mediterranean Diet for Post-menopausal Women: Effects on Bone Turnover https://ClinicalTrials.gov/show/NCT01653275 Completed UConn Health 2014-12-31
NCT01575834 Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis https://ClinicalTrials.gov/show/NCT01575834 Completed Amgen 2015-12-14
NCT01572545 Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin of Postmenopausal Women With Low Bone Mass https://ClinicalTrials.gov/show/NCT01572545 Completed Aristotle University Of Thessaloniki 2012-09-30
NCT01571843 Radius Loading in Primary Hyperparathyroidism https://ClinicalTrials.gov/show/NCT01571843 Completed Columbia University 2014-10-31
NCT01544894 Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosis https://ClinicalTrials.gov/show/NCT01544894 Completed University of Valencia 2011-10-31
NCT01501344 Open-label Study to Evaluate the Effect of MBP-80 on Bone Remodelling https://ClinicalTrials.gov/show/NCT01501344 Completed Groupe De Recherche En Rhumatologie Et Maladies Osseuses Inc. 2011-08-31
NCT01495000 A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab https://ClinicalTrials.gov/show/NCT01495000 Completed GlaxoSmithKline 2013-02-28
NCT01457950 A Study in Korean Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab https://ClinicalTrials.gov/show/NCT01457950 Completed GlaxoSmithKline 2012-12-31
NCT01350934 A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264) https://ClinicalTrials.gov/show/NCT01350934 Completed Merck Sharp & Dohme Corp. 2013-01-10
NCT01348243 Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal Osteoporosis https://ClinicalTrials.gov/show/NCT01348243 Completed Chiesi Farmaceutici S.p.A. 2013-03-31
NCT01343004 Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women https://ClinicalTrials.gov/show/NCT01343004 Completed Radius Health, Inc. 2014-10-31
NCT01321723 Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal Women https://ClinicalTrials.gov/show/NCT01321723 Completed Unigene Laboratories Inc. 2011-10-31
NCT04321837 Coral Calcium’s Effect on Bone Density in Postmenopausal Women With and Without Ibandronate https://ClinicalTrials.gov/show/NCT04321837 Recruiting Columbia University 2021-12-31
NCT04179903 Efficacy and Safety of the Physical Activity Program in Women With Post-menopausal Osteoporosis https://ClinicalTrials.gov/show/NCT04179903 Recruiting Istituto Ortopedico Rizzoli 2020-09-15
NCT04169789 Prevention of Early Postmenopausal Bone Loss With Lactobacillus Reuteri https://ClinicalTrials.gov/show/NCT04169789 Recruiting Sahlgrenska University Hospital, Sweden 2022-08-31
NCT04167150 Tart Cherry Supplementation and Women’s Bone Health Study https://ClinicalTrials.gov/show/NCT04167150 Completed Oklahoma State University 2018-05-31
NCT04149405 Alterations of GCF Levels of Sclerostin and DKK-1 in Postmenopausal Osteoporosis https://ClinicalTrials.gov/show/NCT04149405 Completed Ondokuz Mayıs University 2017-06-30
NCT04128163 Efficacy and Safety of QL1206 in the Treatment of Postmenopausal Osteoporosis With High Fracture Risk https://ClinicalTrials.gov/show/NCT04128163 Recruiting Qilu Pharmaceutical Co., Ltd. 2021-08-31
NCT04063813 Parameters of Exercise to Prevent Osteoporosis https://ClinicalTrials.gov/show/NCT04063813 Completed University of Michigan 2010-08-19
NCT04026256 Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration https://ClinicalTrials.gov/show/NCT04026256 Recruiting Massachusetts General Hospital 2021-11-30
NCT03925051 Phase 1 Study to Compare CMAB807 Injection to Prolia® in Healthy Volunteers https://ClinicalTrials.gov/show/NCT03925051 Active, not recruiting Shanghai Biomabs Pharmaceutical Co., Ltd. 2020-03-21
NCT03910348 Effects of Whole-Body Vibration and High Impact Exercises in Postmenopausal Women https://ClinicalTrials.gov/show/NCT03910348 Completed Istanbul University 2011-05-31
NCT03832088 Sarcopenia And Balance In Postmenopausal Osteoporosis https://ClinicalTrials.gov/show/NCT03832088 Recruiting Istanbul Medeniyet University 2019-03-31
NCT03832075 Validity of Korebalance Balance System https://ClinicalTrials.gov/show/NCT03832075 Recruiting Istanbul Medeniyet University 2019-01-31
NCT03761979 Safety and Pharmacokinetics of Orally Administered Strontium L-Lactate in Healthy Adults https://ClinicalTrials.gov/show/NCT03761979 Completed BioLink Life Sciences, Inc. 2017-06-01
NCT03742362 MRI Study of the Distal Radius Bone Marrow Fat Fraction in Osteoporotic and Healthy Women https://ClinicalTrials.gov/show/NCT03742362 Completed Tel Aviv University 2019-08-30
NCT03720886 G56W1 in Women With Postmenopausal Osteoporosis https://ClinicalTrials.gov/show/NCT03720886 Active, not recruiting Shenzhen Salubris Pharmaceuticals Co., Ltd. 2020-05-31
NCT03710889 Early Effects of Abaloparatide on Tissue-based Indices of Bone Formation and Resorption https://ClinicalTrials.gov/show/NCT03710889 Active, not recruiting Radius Health, Inc. 2019-10-31
NCT03701113 Milk Protein and Bone Health in Postmenopausal Women https://ClinicalTrials.gov/show/NCT03701113 Recruiting University of Limerick 2019-05-31
NCT03623633 Comparative Antiresorptive Efficacy Discontinuation of Denosumab https://ClinicalTrials.gov/show/NCT03623633 Recruiting Massachusetts General Hospital 2021-09-01
NCT03472846 MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis https://ClinicalTrials.gov/show/NCT03472846 Active, not recruiting Medical University of Vienna 2020-12-01
NCT03432533 A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis https://ClinicalTrials.gov/show/NCT03432533 Completed Amgen 2019-04-11
NCT01250145 A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally in Healthy Postmenopausal Women https://ClinicalTrials.gov/show/NCT01250145 Completed Eli Lilly and Company 2011-05-31
NCT01224717 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal Women https://ClinicalTrials.gov/show/NCT01224717 Completed Novartis 2011-04-30
NCT01221727 The Effects of Denosumab on the Pharmacokinetics (PK) of Midazolam https://ClinicalTrials.gov/show/NCT01221727 Completed Amgen 2011-07-31
NCT00996801 MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012) https://ClinicalTrials.gov/show/NCT00996801 Completed Merck Sharp & Dohme Corp. 2011-06-30
NCT00965978 A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulation https://ClinicalTrials.gov/show/NCT00965978 Completed Astellas Pharma Inc 2009-09-30
NCT00959764 A Study Comparing Oral Calcitonin to Nasal Spray Calcitonin in Postmenopausal Osteoporotic Women https://ClinicalTrials.gov/show/NCT00959764 Completed Tarsa Therapeutics, Inc. 2011-02-28
NCT00936897 A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly Bisphosphonates https://ClinicalTrials.gov/show/NCT00936897 Completed Amgen 2011-11-30
NCT00927186 Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women https://ClinicalTrials.gov/show/NCT00927186 Completed Eli Lilly and Company 2010-10-31
NCT00918749 Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women https://ClinicalTrials.gov/show/NCT00918749 Completed Warner Chilcott 2009-10-31
NCT00909961 A Trial Evaluating the Effects of Zoledronic Acid 5 mg Infusion on Bone Mineral Density (BMD) in Postmenopausal Osteoporosis (PMO) Patients Between the Ages of 50 and 65 Years https://ClinicalTrials.gov/show/NCT00909961 Completed Novartis 2011-12-31
NCT00896532 Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density https://ClinicalTrials.gov/show/NCT00896532 Completed Amgen 2011-02-21
NCT00890981 A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With Denosumab https://ClinicalTrials.gov/show/NCT00890981 Completed Amgen 2010-06-30
NCT00887965 A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab https://ClinicalTrials.gov/show/NCT00887965 Completed Amgen 2010-06-30
NCT00860964 A Study of Prevention and Treatment of Postmenopausal Osteoporosis in Chinese Women https://ClinicalTrials.gov/show/NCT00860964 Completed Peking Union Medical College 2003-02-28
NCT02808988 Changes of GCF Levels of RANKL and Osteoprotegerin in Postmenopausal Osteoporosis https://ClinicalTrials.gov/show/NCT02808988 Completed Ondokuz Mayıs University 2015-10-31
NCT04064411 Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis https://ClinicalTrials.gov/show/NCT04064411 Recruiting Radius Health, Inc. 2021-09-30
NCT02157948 A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis https://ClinicalTrials.gov/show/NCT02157948 Completed Amgen 2015-07-31
NCT03816449 Influence of Exercise Program on Serum Matrix Metalloproteinases and Functional Status in Women With Postmenopausal Osteoporosis https://ClinicalTrials.gov/show/NCT03816449 Recruiting Institut za Rehabilitaciju Sokobanjska Beograd 2019-10-30
NCT00745121 Study Evaluating ASTRA TECH Implant System, OsseoSpeedâ„¢ Implants in the Upper Jaw in Women With Osteoporosis https://ClinicalTrials.gov/show/NCT00745121 Completed Dentsply Sirona Implants 2017-11-01
NCT00729651 Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263) https://ClinicalTrials.gov/show/NCT00729651 Completed Merck Sharp & Dohme Corp. 2009-04-10
NCT00718861 3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs https://ClinicalTrials.gov/show/NCT00718861 Completed Novartis 2013-04-30
NCT00676312 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of PTH134 at Increasing Doses in Healthy Postmenopausal Subjects https://ClinicalTrials.gov/show/NCT00676312 Completed Novartis 2008-08-31
NCT00674453 The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine Evaluation https://ClinicalTrials.gov/show/NCT00674453 Completed Ligand Pharmaceuticals NA
NCT00670501 Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis https://ClinicalTrials.gov/show/NCT00670501 Completed Eli Lilly and Company 1999-04-30
NCT00670319 Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis https://ClinicalTrials.gov/show/NCT00670319 Completed Eli Lilly and Company 1999-09-30
NCT00666627 Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects https://ClinicalTrials.gov/show/NCT00666627 Completed Sheffield Teaching Hospitals NHS Foundation Trust 2012-09-30
NCT00659906 Optimizing Body Composition & Health After Breast Cancer https://ClinicalTrials.gov/show/NCT00659906 Completed OHSU Knight Cancer Institute 2009-01-31
NCT00632216 A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis https://ClinicalTrials.gov/show/NCT00632216 Completed Sanofi NA
NCT00620113 Efficacy and Safety of Odanacatib (MK-0822) in Participants With Involutional Osteoporosis (MK-0822-022) https://ClinicalTrials.gov/show/NCT00620113 Completed Merck Sharp & Dohme Corp. 2009-05-29
NCT00591747 Strength Training for Older Breast Cancer Survivors https://ClinicalTrials.gov/show/NCT00591747 Completed OHSU Knight Cancer Institute 2009-01-31
NCT00578981 Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal Women https://ClinicalTrials.gov/show/NCT00578981 Completed Mayo Clinic 2008-07-31
NCT00577421 Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMO https://ClinicalTrials.gov/show/NCT00577421 Completed Warner Chilcott NA
NCT00567606 Prevention of Osteoporosis in Breast Cancer Survivors https://ClinicalTrials.gov/show/NCT00567606 Completed University of Nebraska NA
NCT01232647 Vitamin K as Additive Treatment in Osteoporosis https://ClinicalTrials.gov/show/NCT01232647 Active, not recruiting Guy’s and St Thomas’ NHS Foundation Trust 2020-03-31
NCT00557310 A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide https://ClinicalTrials.gov/show/NCT00557310 Completed Eli Lilly and Company 2010-10-31
NCT00551174 A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment https://ClinicalTrials.gov/show/NCT00551174 Completed Hoffmann-La Roche 2008-11-30
NCT00549965 Satisfaction and Compliance of Risedronate in PMO https://ClinicalTrials.gov/show/NCT00549965 Completed Sanofi NA
NCT00549068 POWER Point of Care Effect on Satisfaction of Treatment https://ClinicalTrials.gov/show/NCT00549068 Completed Sanofi NA
NCT00545909 BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis https://ClinicalTrials.gov/show/NCT00545909 Completed Hoffmann-La Roche 2008-08-31
NCT00545779 BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy. https://ClinicalTrials.gov/show/NCT00545779 Completed Hoffmann-La Roche 2008-10-31
NCT00545480 SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis. https://ClinicalTrials.gov/show/NCT00545480 Completed Hoffmann-La Roche 2009-03-31
NCT00545363 A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP) https://ClinicalTrials.gov/show/NCT00545363 Completed Hoffmann-La Roche 2008-01-31
NCT00545090 ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis. https://ClinicalTrials.gov/show/NCT00545090 Completed Hoffmann-La Roche 2008-06-30
NCT00545051 A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis. https://ClinicalTrials.gov/show/NCT00545051 Completed Hoffmann-La Roche 2009-05-31
NCT00543218 PTH Comparison in Post Menopausal Women https://ClinicalTrials.gov/show/NCT00543218 Completed Eli Lilly and Company NA
NCT00543023 A Study of the Treatment of Postmenopausal Women With Osteoporosis https://ClinicalTrials.gov/show/NCT00543023 Completed Eli Lilly and Company NA
NCT00542984 Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis https://ClinicalTrials.gov/show/NCT00542984 Completed Eli Lilly and Company NA
NCT00541658 A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis https://ClinicalTrials.gov/show/NCT00541658 Completed Warner Chilcott 2010-04-30
NCT00533650 Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005) https://ClinicalTrials.gov/show/NCT00533650 Completed Merck Sharp & Dohme Corp. 2002-10-31
NCT00532545 Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis https://ClinicalTrials.gov/show/NCT00532545 Completed Eli Lilly and Company NA
NCT00532428 Long Term Effects of Raloxifene Treatment on Bone Quality https://ClinicalTrials.gov/show/NCT00532428 Completed Eli Lilly and Company NA
NCT00532246 Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo https://ClinicalTrials.gov/show/NCT00532246 Completed Eli Lilly and Company NA
NCT00532207 Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis https://ClinicalTrials.gov/show/NCT00532207 Completed Eli Lilly and Company NA
NCT00503113 A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease. https://ClinicalTrials.gov/show/NCT00503113 Completed Hoffmann-La Roche 2010-04-30
NCT00453492 Risedronate Sodium in Post Menopausal Osteoporosis https://ClinicalTrials.gov/show/NCT00453492 Completed Sanofi NA
NCT00411125 Pharmacokinetics and Pharmacodynamics Study of Oral Salmon Calcitonin in Healthy Postmenopausal Women https://ClinicalTrials.gov/show/NCT00411125 Completed Novartis NA
NCT00405392 Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis https://ClinicalTrials.gov/show/NCT00405392 Completed GlaxoSmithKline 2008-05-27
NCT00402441 Risedronate in the Prevention of Osteoporosis in Postmenopausal Women https://ClinicalTrials.gov/show/NCT00402441 Completed Sanofi 2004-06-30
NCT00398931 FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051) https://ClinicalTrials.gov/show/NCT00398931 Completed Merck Sharp & Dohme Corp. 2003-10-31
NCT00398606 A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED) https://ClinicalTrials.gov/show/NCT00398606 Completed Merck Sharp & Dohme Corp. 1998-02-28
NCT00395395 Effects of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of Oral Salmon Calcitonin in Healthy Postmenopausal Women https://ClinicalTrials.gov/show/NCT00395395 Completed Novartis NA
NCT00389740 A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189) https://ClinicalTrials.gov/show/NCT00389740 Completed Merck Sharp & Dohme Corp. 2003-01-16
NCT00383422 Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis https://ClinicalTrials.gov/show/NCT00383422 Completed Eli Lilly and Company 2008-07-31
NCT00381251 Study Comparing Bioequivalence of Two New Formulations of Premarin/MPA With Premarin/MPA Reference Formulation. https://ClinicalTrials.gov/show/NCT00381251 Completed Wyeth is now a wholly owned subsidiary of Pfizer NA
NCT00377819 Study of Transitioning From Alendronate to Denosumab https://ClinicalTrials.gov/show/NCT00377819 Completed Amgen 2008-03-31
NCT00377234 A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis. https://ClinicalTrials.gov/show/NCT00377234 Completed Hoffmann-La Roche 2008-08-31
NCT00358176 Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women https://ClinicalTrials.gov/show/NCT00358176 Completed Sanofi 2007-03-31
NCT00357331 The Effects of Potassium Citrate on Bone Metabolism https://ClinicalTrials.gov/show/NCT00357331 Completed Weill Medical College of Cornell University 2011-04-30
NCT00353080 Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women https://ClinicalTrials.gov/show/NCT00353080 Completed Sanofi 2005-04-30
NCT00351091 Risedronate in Postmenopausal Women With Low Bone Density https://ClinicalTrials.gov/show/NCT00351091 Completed Sanofi 2003-06-30
NCT00343252 Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis https://ClinicalTrials.gov/show/NCT00343252 Completed Eli Lilly and Company 2009-06-30
NCT00303485 A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate) https://ClinicalTrials.gov/show/NCT00303485 Completed Hoffmann-La Roche 2007-06-30
NCT00293813 A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density https://ClinicalTrials.gov/show/NCT00293813 Completed Amgen 2008-03-31
NCT00290212 Natto Supplementation to Prevent Loss of Bone Mass in Women Immediately After Menopause https://ClinicalTrials.gov/show/NCT00290212 Completed University Hospital of North Norway NA
NCT00271713 Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D) https://ClinicalTrials.gov/show/NCT00271713 Completed Charite University, Berlin, Germany 2007-09-30
NCT00247273 A Study of Monthly Risedronate for Osteoporosis https://ClinicalTrials.gov/show/NCT00247273 Completed Warner Chilcott 2008-03-31
NCT00239629 Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial https://ClinicalTrials.gov/show/NCT00239629 Completed Eli Lilly and Company NA
NCT00238745 Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis. https://ClinicalTrials.gov/show/NCT00238745 Completed Wyeth is now a wholly owned subsidiary of Pfizer NA
NCT00222872 3-Week Parathyroid Hormone-related Protein (PTHrP) Dose Escalation Study in Post-Menopausal Women https://ClinicalTrials.gov/show/NCT00222872 Completed University of Pittsburgh 2008-09-30
NCT00191425 2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis https://ClinicalTrials.gov/show/NCT00191425 Completed Eli Lilly and Company NA
NCT00172107 A Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal Osteoporosis https://ClinicalTrials.gov/show/NCT00172107 Completed Shire 1997-03-31
NCT00172081 TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis https://ClinicalTrials.gov/show/NCT00172081 Completed Shire 2003-11-30
NCT00168909 Influence of Alfacalcidol on Falls in Osteopenic/Osteoporotic Postmenopausal Women (ALFA Study) https://ClinicalTrials.gov/show/NCT00168909 Completed Charite University, Berlin, Germany 2007-07-31
NCT00165698 Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women https://ClinicalTrials.gov/show/NCT00165698 Completed Eisai Inc. 2007-01-31
NCT00165204 Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic Oophorectomy https://ClinicalTrials.gov/show/NCT00165204 Completed Dana-Farber Cancer Institute 2006-03-31
NCT00150969 Vitamin K Supplementation in Post-Menopausal Osteopenia https://ClinicalTrials.gov/show/NCT00150969 Completed University Health Network, Toronto 2006-09-30
NCT00145977 Texture Analysis for Postmenopausal Osteoporosis https://ClinicalTrials.gov/show/NCT00145977 Completed University of Chicago 2009-12-31
NCT00130403 OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women https://ClinicalTrials.gov/show/NCT00130403 Completed Sanofi NA
NCT00092053 Study of Investigational Drug in Osteoporosis (MK-0217-908) https://ClinicalTrials.gov/show/NCT00092053 Completed Merck Sharp & Dohme Corp. 2005-07-31
NCT00092040 A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907) https://ClinicalTrials.gov/show/NCT00092040 Completed Merck Sharp & Dohme Corp. 2004-10-18
NCT00092027 A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219) https://ClinicalTrials.gov/show/NCT00092027 Completed Merck Sharp & Dohme Corp. 2004-03-15
NCT00092014 A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211) https://ClinicalTrials.gov/show/NCT00092014 Completed Merck Sharp & Dohme Corp. 2004-04-01
NCT00091793 Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis https://ClinicalTrials.gov/show/NCT00091793 Completed Amgen 2009-02-28
NCT00088010 Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer https://ClinicalTrials.gov/show/NCT00088010 Completed Eli Lilly and Company 2009-06-30
NCT00086619 Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women https://ClinicalTrials.gov/show/NCT00086619 Completed Massachusetts General Hospital 2009-12-31
NCT00085956 Effects of Arzoxifene on Bone Mass and the Uterus https://ClinicalTrials.gov/show/NCT00085956 Completed Eli Lilly and Company NA
NCT00081653 A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva https://ClinicalTrials.gov/show/NCT00081653 Completed Hoffmann-La Roche 2007-11-30
NCT00079924 Effects of Teriparatide in Postmenopausal Women With Osteoporosis https://ClinicalTrials.gov/show/NCT00079924 Completed Eli Lilly and Company NA
NCT00073190 Patient- and Physician-Based Osteoporosis Education https://ClinicalTrials.gov/show/NCT00073190 Completed Brigham and Women’s Hospital 2006-06-30
NCT00010712 Effects of Black Cohosh on Menopausal Hot Flashes https://ClinicalTrials.gov/show/NCT00010712 Completed National Center for Complementary and Integrative Health (NCCIH) NA
NCT00048074 DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis https://ClinicalTrials.gov/show/NCT00048074 Completed Hoffmann-La Roche 2005-05-31
NCT00048061 MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis https://ClinicalTrials.gov/show/NCT00048061 Completed Hoffmann-La Roche 2004-12-31
NCT00046137 Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis https://ClinicalTrials.gov/show/NCT00046137 Completed Eli Lilly and Company NA
NCT00035256 Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis https://ClinicalTrials.gov/show/NCT00035256 Completed Eli Lilly and Company NA
NCT00018447 Combination Osteogenic Therapy in Established Osteoporosis https://ClinicalTrials.gov/show/NCT00018447 Completed VA Office of Research and Development NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03304743 Dental Panoramic Radiographs to Screen for Post-menopausal Osteoporosis https://ClinicalTrials.gov/show/NCT03304743 Recruiting University of Parma 2019-06-30
NCT03125590 Validation, Reliability and Pilot Test of the Personalized Exercise Questionnaire (PEQ) https://ClinicalTrials.gov/show/NCT03125590 Completed McMaster University 2017-07-09
NCT02422069 Study of Post Menopausal Osteoporosis (PMO) Among Gynecology Outpatients in Pakistan https://ClinicalTrials.gov/show/NCT02422069 Completed Hoffmann-La Roche 2011-12-31
NCT02347865 Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France https://ClinicalTrials.gov/show/NCT02347865 Completed Amgen 2017-10-26
NCT02271204 Observational Study of iv Ibandronate in Women With Postmenopausal Osteoporosis https://ClinicalTrials.gov/show/NCT02271204 Completed Clinic of Endocrinology and Metabolic Disorders, Macedonia 2013-04-30
NCT02234414 Epidemiology, Identification Rate and Treatment Penetration of Osteoporotic Vertebral Fractures in Switzerland https://ClinicalTrials.gov/show/NCT02234414 Completed Interessengemeinschaft Osteoporose 2010-09-30
NCT02184962 Periodontal Disease and Post-menopausal Osteoporosis https://ClinicalTrials.gov/show/NCT02184962 Completed Universidad Nacional de Córdoba 2013-09-30
NCT02157753 Quality of the Detection & Treatment of Osteoporotic Fractures in a Swiss Trauma Center https://ClinicalTrials.gov/show/NCT02157753 Completed Kantonsspital Aarau 2015-10-31
NCT01668589 Observational Study of Denosumab (Prolia®) in Postmenopausal Women With Osteoporosis https://ClinicalTrials.gov/show/NCT01668589 Completed Amgen 2015-08-31
NCT01652690 Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Denosumab (Prolia®) in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT01652690 Completed Amgen 2015-05-15
NCT01416194 Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU) https://ClinicalTrials.gov/show/NCT01416194 Completed Pfizer 2019-04-30
NCT01406613 Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis https://ClinicalTrials.gov/show/NCT01406613 Completed Sheffield Teaching Hospitals NHS Foundation Trust 2015-11-30
NCT01401114 Wellnara Post-marketing Surveillance in Japan https://ClinicalTrials.gov/show/NCT01401114 Completed Bayer 2014-08-31
NCT01397955 Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan https://ClinicalTrials.gov/show/NCT01397955 Completed Bayer 2014-01-31
NCT01386281 Julina Post-marketing Surveillance for Climacteric Symptoms in Japan https://ClinicalTrials.gov/show/NCT01386281 Completed Bayer 2014-04-15
NCT01381588 The Prevalence of Osteoporotic Vertebral Compression Fractures (OVCF) in Korean Post Menopausal Women https://ClinicalTrials.gov/show/NCT01381588 Completed GlaxoSmithKline 2011-02-28
NCT04338529 Alendronate in an Weekly Effervescent Tablet Formulation Following Denosumab Discontinuation https://ClinicalTrials.gov/show/NCT04338529 Recruiting 251 Hellenic Air Force & VA General Hospital 2021-10-01
NCT04206618 Circulating Myokine Levels and Bone Metabolism https://ClinicalTrials.gov/show/NCT04206618 Recruiting 424 General Military Hospital 2020-06-30
NCT04029870 Psychological Determinants of the Therapeutic Observance of Osteoporotic Patients https://ClinicalTrials.gov/show/NCT04029870 Recruiting Centre Hospitalier Régional Metz-Thionville 2022-06-30
NCT04019938 Association of Cystatin C and Bone Mineral Density in Diabetic Patients. https://ClinicalTrials.gov/show/NCT04019938 Recruiting Fifth Affiliated Hospital, Sun Yat-Sen University 2019-12-25
NCT03895333 Hearing Loss and Osteoporosis https://ClinicalTrials.gov/show/NCT03895333 Completed Kanuni Sultan Suleyman Training and Research Hospital 2020-03-01
NCT01128257 A Study of Ibandronate [Bonviva/Boniva] and Alendronate in Female Patients With Post-Menopausal Osteoporosis https://ClinicalTrials.gov/show/NCT01128257 Completed Hoffmann-La Roche 2011-12-31
NCT01064453 Angeliq Regulatory Post Marketing Surveillance https://ClinicalTrials.gov/show/NCT01064453 Completed Bayer 2012-12-31
NCT00984893 Intra-venous Zoledronic Acid Once Yearly https://ClinicalTrials.gov/show/NCT00984893 Completed Novartis 2014-04-30
NCT03878732 Bindex for Osteoporosis Diagnostics https://ClinicalTrials.gov/show/NCT03878732 Completed Bone Index Finland Ltd 2020-02-07
NCT03692143 Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVP https://ClinicalTrials.gov/show/NCT03692143 Active, not recruiting Nanfang Hospital of Southern Medical University 2025-03-01
NCT01227369 Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment https://ClinicalTrials.gov/show/NCT01227369 Completed GlaxoSmithKline 2009-11-30
NCT00778154 Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate https://ClinicalTrials.gov/show/NCT00778154 Completed Warner Chilcott 2006-12-31
NCT00696644 A Study for Teriparatide in Severe Osteoporosis https://ClinicalTrials.gov/show/NCT00696644 Completed Eli Lilly and Company 2011-04-30
NCT00515593 PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE) https://ClinicalTrials.gov/show/NCT00515593 Completed Nycomed NA
NCT00399321 A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer https://ClinicalTrials.gov/show/NCT00399321 Completed University of Michigan Rogel Cancer Center 2010-09-30
NCT00221312 Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss https://ClinicalTrials.gov/show/NCT00221312 Completed University of California, San Francisco NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02472782 Adherence to Osteoporosis Treatment and Physicians’ Perception Regarding Osteoporosis Medication https://ClinicalTrials.gov/show/NCT02472782 Completed 251 Hellenic Air Force & VA General Hospital 2018-06-30
NCT02128009 Study on the microRNA Expression Level in Postmenopausal Osteoporosis https://ClinicalTrials.gov/show/NCT02128009 Completed Fujian Academy of Traditional Chinese Medicine 2016-12-31
NCT03970902 Quality of Life in Postmenopausal Women With Osteoporosis https://ClinicalTrials.gov/show/NCT03970902 Recruiting University Ghent 2021-12-31
NCT03931109 Circulating miRNA in Primary Hyperparathyroidism https://ClinicalTrials.gov/show/NCT03931109 Active, not recruiting University of Pennsylvania 2021-09-30